Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Weinland divides neurotech into invasive devices for disabilities—restoring sight or limb use—and noninvasive consumer devices for ADHD, focus and sleep. He tried a sleep device and felt it pumping microwaves into his brain without relaxing, but he still expects many people could use such devices within a decade.

Related Insights

Early human augmentation startups used Transcranial Direct Current Stimulation (TDCS) to create wearable devices that could induce specific mental states. One version acted as a stimulant, like "digital caffeine," while another induced relaxation, like "digital cannabis," by delivering low-voltage electricity to specific brain regions.

The performance ceiling for non-invasive Brain-Computer Interfaces (BCIs) is rising dramatically, not from better sensors, but from advanced AI. New models can extract high-fidelity signals from noisy data collected outside the skull, potentially making surgical implants like Neuralink unnecessary for sophisticated use cases.

Frontier AI labs like Meta, OpenAI, and Anthropic are ultimately tracking toward becoming biotechnology platforms. While the public focuses on large language models, the real competitive frontier involves dynamically reading and writing to human brain circuits non-invasively. By pairing AI with modalities like focused ultrasound, these companies aim to modulate motivation, alertness, and learning in real time by titrating activity in specific subcortical regions such as the nucleus accumbens.

The sci-fi allure of brain implants and embedded chips often overshadows practical alternatives. Ariel Poler argues that most desired functionalities, from interfacing with AI to carrying identification, can be achieved with less invasive external devices like advanced hearables or wearables, questioning the necessity of risky surgical augmentation for healthy individuals.

Challenging Neuralink's implant-based BCI, Merge Labs is creating a new paradigm using molecules, proteins, and ultrasound. This less invasive approach aims for higher bandwidth by interfacing with millions of neurons, fundamentally rethinking how to connect brains to machines.

While current brain-computer interfaces (BCIs) are for medical patients, the timeline for healthy individuals to augment their brains is rapidly approaching. A child who is five years old today might see the first healthy human augmentations before they graduate high school, signaling a near-term, transformative shift for society.

While 'reading' from the nervous system (e.g., HRV tracking) is common, 'writing' to it is the next step. Huberman predicts the first successful consumer applications will be for sleep, as the outcome is highly objective. Technologies like mechanically rocking beds or eye-movement-stimulating masks are early examples.

Current wearables passively track sleep. The next generation of technology will actively induce and manage sleep by 'writing' to our biology—for example, using devices that directly cool the body's core through the palms or eye masks that guide eye movements to accelerate sleep onset.

Future consumer neuro-enhancement will likely avoid invasive skull drilling by combining harmless viral vectors with external wearable devices. Adeno-associated viruses can deliver genetic ion channels into specific neural populations. Once integrated, wearable hardware like caps emitting deep-penetrating light or focused ultrasound can selectively modulate those sensitized neurons. This enables fine-grained titration of focus and motivation without intracranial implants, provided proper regulatory and safety boundaries exist.

Huberman argues that the most practical near-term path to 'writing' to the brain for focus or sleep isn't through complex implants but through the eyes and surrounding nerves. Technologies like smart glasses or sleep masks can leverage this direct neural pathway to powerfully and safely modify brain states.